I’ve written previously about the launch and on-going marketing campaign for Cymbalta and the links that Lilly are keen to establish – recasting depression’s association with “vague aches and pains of varying degrees of severity” into a full blown campaign… which may or may not smack of off-label promotion.
Here’s some more on Cymbalta from the Independent:
Was Traci Johnson driven to suicide by anti-depressants? That’s a trade secret, say US officials…
Researchers trying to establish the truth about a new drug – now on sale in the UK – are being thwarted by a government agency whose job is to protect the public
By Jeanne Lenzer and Nicholas Pyke, published: 19 June 2005
When the body of a 19-year-old student, Traci Johnson, was found hanging from a shower rod in the laboratories of pharmaceuticals giant Eli Lilly, US officials were quick to announce that the death could not be linked to a new anti-depressant drug she was helping to test.
During her stay at the hotel-cum-clinic in Indiana known as the Lilly Lab, Johnson had been taking part in trials for a secret new formula called Cymbalta, a chemical cousin of Prozac, which the company hoped would guarantee huge profits for years to come.
Read the full article here.